We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Glucose Intolerance and Risk Factors in Ethiopian Immigrants in Israel; Follow-up Study.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2011 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01402362
First Posted: July 26, 2011
Last Update Posted: July 26, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Hillel Yaffe Medical Center
  Purpose
High risk population: Screening for impaired glucose tolerance.

Condition
Diabetes Mellitus Glucose Intolerance

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by Hillel Yaffe Medical Center:

Primary Outcome Measures:
  • Percent of patients with Diabetes Mellitus or impaired glucose tolerance [ Time Frame: Day 1 of study ]

Secondary Outcome Measures:
  • Prevalence of hypertension and hyperlipidemia [ Time Frame: Day 1 of study ]

Estimated Enrollment: 550
Study Start Date: September 2011
Groups/Cohorts
Ethiopians participating in previous study, year 2000

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   25 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Ethiopian immigrants to Israel living in Hadera.
Criteria

Inclusion Criteria:

  • Participation in the year 2000 study
  • Signature of Informed Consent Form

Exclusion Criteria:

Pregnancy

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01402362


Contacts
Contact: Anat Jaffe, MD PhD +97246304748 Jaffe@hy.health.gov.il

Locations
Israel
Diabetes and Endocrinology Unit, Hillel Yaffe MC, POB169 Not yet recruiting
Hadera, Israel, 38100
Contact: Anat Jaffe, MD PhD    +97246304748    jaffe@hy.health.gov.il   
Sub-Investigator: Liana Tripto, MD         
Principal Investigator: Anat Jaffe, MD PhD         
Sponsors and Collaborators
Hillel Yaffe Medical Center
  More Information

Responsible Party: Diabetes and Endocrinology Unit, Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT01402362     History of Changes
Other Study ID Numbers: 56-2011
First Submitted: July 24, 2011
First Posted: July 26, 2011
Last Update Posted: July 26, 2011
Last Verified: June 2011

Keywords provided by Hillel Yaffe Medical Center:
Ethiopians
Diabetes Mellitus
Glucose tolerance
Israel
Included in the year 2000 study

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Intolerance
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Hyperglycemia